查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609161

神经病学病患监测市场：按设备、疾病类型和最终用户划分 - 全球预测 2025-2030

Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年神经病学病患监测市场价值为51.8亿美元，预计到2024年将达到55.5亿美元，复合年增长率为7.90%，预计到2030年将达到88.4亿美元。

神经病学病患监测市场包括透过评估各种生理和解剖参数来追踪神经状况的技术和设备。这个市场对于治疗癫痫、创伤性脑损伤、帕金森氏症和中风等疾病至关重要。神经病学病患监测的需求在于需要对神经系统疾病进行准确诊断和有效管理，从而实现即时资料收集和关键决策以改善患者治疗结果。应用范围包括医院、诊所和居家照护，最终用户包括神经科、医疗保健专业人员和患者本身。关键的市场驱动因素包括神经系统疾病盛行率的增加、监测技术的进步以及对神经系统健康意识的增强。此外，远端医疗和远端患者监护的成长创造了潜在的机会，特别是在医疗保健机会有限的地区。特别是，将人工智慧和机器学习整合到监控系统中进行预测分析和自动化，代表着一个快速成长的机会。

主要市场统计
基准年[2023] 51.8亿美元
预测年份 [2024] 55.5亿美元
预测年份 [2030] 88.4亿美元
复合年增长率（%） 7.90%

然而，挑战依然存在，例如复杂的监测设备和资源匮乏地区基础设施有限带来的高成本。办理复杂的监管审批也是新参与企业进入市场的障碍。此外，数位监控解决方案中的资料隐私和安全问题需要仔细考虑和强大的解决方案。创新的最佳领域包括开发具有成本效益的便携式监测系统、增强资料分析能力以及改进用户友好的介面以实现更广泛的采用。整合各种感测技术的多模态监测系统的研究可以为市场带来显着的好处。这个市场的本质是竞争性和快速发展，其特点是新技术的不断出现以及老牌和新兴企业的进入。为了抓住市场机会，企业应注重策略伙伴关係关係，开拓开拓的市场，并优先开拓以使用者为中心的产品。透过专注于全面的客户支援并利用数位健康领域的进步，我们相信我们可以进一步加强我们的市场定位并推动永续成长。

市场动态：快速发展的神经病学病患监测市场的关键市场洞察

供需的动态交互作用正在改变神经病学病患监测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对微创神经外科手术的偏好日益增长
    • 全球神经系统疾病负担日益增加
    • 增加神经系统疾病意识提升计划
  • 市场限制因素
    • 神经外科费用上涨
  • 市场机会
    • 融合先进技术
    • 有利的赎回场景
  • 市场挑战
    • 世界神经外科医师短缺

波特五力：驾驭神经病学病患监测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解神经病学病患监测市场的外部影响

外部宏观环境因素在塑造神经病学病患监测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解神经病学病患监测市场的竞争格局

对神经病学病患监测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵神经病学病患监测市场供应商的绩效评估

FPNV 定位矩阵是评估神经科病患监测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了神经病学病患监测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对神经病学病患监测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人们对微创神经外科的兴趣日益浓厚
      • 世界各地神经系统疾病的负担不断增加
      • 扩大对神经系统疾病的认识计划
    • 抑制因素
      • 神经外科费用上涨
    • 机会
      • 融合先进技术
      • 有利的赎回场景
    • 任务
      • 全球神经外科医师短缺
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 神经病学病患监测市场：依设备分类

  • 脑氧饱和度仪
  • 脑波监测仪
  • 颅内压监测仪
  • 磁振造影(MRI) 设备

第七章神经病学病患监测市场：依疾病类型

  • 癫痫
  • 帕金森氏症
  • 睡眠障碍
  • 中风和偏头痛
  • 创伤性脑损伤 (TBI)

第 8 章 神经病学病患监测市场：依最终使用者分类

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 神经病学中心

第九章美洲神经病学病患监测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太神经病学病患监测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的神经病学病患监测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Advanced Brain Monitoring, Inc.
  • Digitimer Ltd.
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • General Electric Company
  • Integra LifeSciences Corporation
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic PLC
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • NovaSignal Corporation
  • RAUMEDIC AG
  • SOPHYSA SA
  • Spiegelberg GmbH & Co. KG.
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market was valued at USD 5.18 billion in 2023, expected to reach USD 5.55 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 8.84 billion by 2030.

The neurology patient monitoring market encompasses technologies and devices that track neurological conditions by assessing various physiological and anatomical parameters. This market is pivotal for managing conditions such as epilepsy, traumatic brain injuries, Parkinson's disease, and stroke. The necessity for neurology patient monitoring lies in the need for precise diagnosis and effective management of neurological disorders, enabling real-time data collection and critical decision-making for improved patient outcomes. Applications span across hospitals, clinics, and homecare settings, with end-users including neurologists, healthcare professionals, and patients themselves. Key market drivers include the increasing prevalence of neurological disorders, advancements in monitoring technologies, and heightened awareness of neurological health. Furthermore, the growth of telemedicine and remote patient monitoring creates potential opportunities, especially in regions with limited healthcare access. Notably, the integration of artificial intelligence and machine learning for predictive analytics and automation in monitoring systems represents a burgeoning opportunity for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.18 billion
Estimated Year [2024] USD 5.55 billion
Forecast Year [2030] USD 8.84 billion
CAGR (%) 7.90%

However, challenges persist, including high costs associated with advanced monitoring devices and limited infrastructure in low-resource areas. Navigating the complexities of regulatory approvals also poses barriers to market entry for new players. Moreover, data privacy and security concerns in digital monitoring solutions demand careful consideration and robust solutions. The best areas for innovation include developing cost-effective and portable monitoring systems, enhancing data analytics capabilities, and improving user-friendly interfaces for broader adoption. Research into multimodal monitoring systems integrating different sensing technologies could yield significant market advantages. The nature of this market is highly competitive and rapidly evolving, characterized by the continuous emergence of new technologies and the participation of both established players and startups. To capitalize on market opportunities, businesses should focus on strategic partnerships, explore untapped markets, and prioritize user-centric product development. Emphasizing comprehensive customer support and leveraging advancements in digital health could further solidify market positioning and drive sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurology Patient Monitoring Market

The Neurology Patient Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising preference for minimally invasive neurosurgeries
    • Increasing burden of neurological disorders across the globe
    • Growing awareness programs for neurological disorders
  • Market Restraints
    • Elevated cost of neurosurgeries
  • Market Opportunities
    • Integration of advanced technologies
    • Favorable reimbursement scenario
  • Market Challenges
    • Shortage of neurosurgeons across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neurology Patient Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurology Patient Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurology Patient Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurology Patient Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurology Patient Monitoring Market

A detailed market share analysis in the Neurology Patient Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurology Patient Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurology Patient Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurology Patient Monitoring Market

A strategic analysis of the Neurology Patient Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurology Patient Monitoring Market, highlighting leading vendors and their innovative profiles. These include Advanced Brain Monitoring, Inc., Digitimer Ltd., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, General Electric Company, Integra LifeSciences Corporation, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Natus Medical Incorporated, Nihon Kohden Corporation, NovaSignal Corporation, RAUMEDIC AG, SOPHYSA SA, and Spiegelberg GmbH & Co. KG..

Market Segmentation & Coverage

This research report categorizes the Neurology Patient Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors, and Magnetic Resonance Imaging (MRI) Devices.
  • Based on Disease Type, market is studied across Epilepsy, Parkinson's Disease, Sleep Disorders, Stroke & Migraine, and Traumatic Brain Injury (TBI).
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Neurology Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising preference for minimally invasive neurosurgeries
      • 5.1.1.2. Increasing burden of neurological disorders across the globe
      • 5.1.1.3. Growing awareness programs for neurological disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Elevated cost of neurosurgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies
      • 5.1.3.2. Favorable reimbursement scenario
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of neurosurgeons across the globe
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurology Patient Monitoring Market, by Device

  • 6.1. Introduction
  • 6.2. Cerebral Oximeters
  • 6.3. Electroencephalography Monitors
  • 6.4. Intracranial Pressure Monitors
  • 6.5. Magnetic Resonance Imaging (MRI) Devices

7. Neurology Patient Monitoring Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Epilepsy
  • 7.3. Parkinson's Disease
  • 7.4. Sleep Disorders
  • 7.5. Stroke & Migraine
  • 7.6. Traumatic Brain Injury (TBI)

8. Neurology Patient Monitoring Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals
  • 8.5. Neurology Centers

9. Americas Neurology Patient Monitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurology Patient Monitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurology Patient Monitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Brain Monitoring, Inc.
  • 2. Digitimer Ltd.
  • 3. Dragerwerk AG & Co. KGaA
  • 4. Edwards Lifesciences Corporation
  • 5. General Electric Company
  • 6. Integra LifeSciences Corporation
  • 7. Koninklijke Philips N.V.
  • 8. Masimo Corporation
  • 9. Medtronic PLC
  • 10. Natus Medical Incorporated
  • 11. Nihon Kohden Corporation
  • 12. NovaSignal Corporation
  • 13. RAUMEDIC AG
  • 14. SOPHYSA SA
  • 15. Spiegelberg GmbH & Co. KG.

LIST OF FIGURES

  • FIGURE 1. NEUROLOGY PATIENT MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROLOGY PATIENT MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROLOGY PATIENT MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROLOGY PATIENT MONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CEREBRAL OXIMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE & MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEUROLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2023